"Evaluation of Endothelial Dysfunction Using the Flow Mediated Dilation Test in a Population of Chronic Renal Failure Patients at Different Stages, and Evaluation of the Role of Antiphospholipid Antibodies"

NARecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

October 17, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Chronic Renal Failure

Interventions

PROCEDURE

Urine sampling

PROCEDURE

Blood sampling

DEVICE

Flow mediated dilatation test

The flow mediated dilation (FMD) test is the most commonly utilized, non-invasive, ultrasound assessment of endothelial function in humans.

Trial Locations (1)

RECRUITING

Brugmann University Hospital, Brussels

All Listed Sponsors

lead

Brugmann University Hospital

OTHER